VISTAGEN THERAPEUTICS INC (VTGN): Institutional Ownership
Hedge funds and institutional managers reporting a position in VTGN · Health Care. Based on the most recent 13F filing from each holder, sourced from SEC EDGAR.
Reported Holders
8
13F filers
Aggregate Value
$941K
Across holders
Last Price
$0.70
2026-06-26
Sector
Health Care
GICS
Holder activity3 new4 added1 reduced
| Manager⇅ | Type⇅ | Shares⇅ | Market Value▼ | % of Total⇅ | % of Portfolio⇅ | Action⇅ | QoQ Change⇅ | Quarter⇅ |
|---|---|---|---|---|---|---|---|---|
| TWO SIGMA INVESTMENTS, LP CIK 0001179392 | Hedge Fund | 470K | $268K | 28.5% | 0.0% | Added | +$157K | Q1 2026 |
| Walleye Capital LLC CIK 0001758720 | Hedge Fund | 68K | $241K | 25.6% | 0.0% | New | — | Q3 2025 |
| RENAISSANCE TECHNOLOGIES LLC CIK 0001037389 | Hedge Fund | 291K | $166K | 17.7% | 0.0% | Added | +$75K | Q1 2026 |
| CITADEL ADVISORS LLC CIK 0001423053 | Hedge Fund | 239K | $137K | 14.5% | 0.0% | Reduced | $-129K | Q1 2026 |
| TUDOR INVESTMENT CORP ET AL CIK 0000923093 | Hedge Fund | 106K | $61K | 6.4% | 0.0% | Added | +$17K | Q1 2026 |
| Qube Research & Technologies Ltd CIK 0001729829 | Hedge Fund | 60K | $40K | 4.2% | 0.0% | New | — | Q4 2025 |
| Schonfeld Strategic Advisors LLC CIK 0001665241 | Hedge Fund | 27K | $15K | 1.6% | 0.0% | Added | +$3K | Q1 2026 |
| MARSHALL WACE, LLP CIK 0001318757 | Hedge Fund | 20K | $13K | 1.4% | 0.0% | New | — | Q4 2025 |
Added
Hedge Fund
$268K· 28.5% of total· 0.0% port· 470K sh· +$157K QoQ· Q1 2026
New
Hedge Fund
$241K· 25.6% of total· 0.0% port· 68K sh· — QoQ· Q3 2025
Added
Hedge Fund
$166K· 17.7% of total· 0.0% port· 291K sh· +$75K QoQ· Q1 2026
Reduced
Hedge Fund
$137K· 14.5% of total· 0.0% port· 239K sh· $-129K QoQ· Q1 2026
Added
Hedge Fund
$61K· 6.4% of total· 0.0% port· 106K sh· +$17K QoQ· Q1 2026
New
Hedge Fund
$40K· 4.2% of total· 0.0% port· 60K sh· — QoQ· Q4 2025
Added
Hedge Fund
$15K· 1.6% of total· 0.0% port· 27K sh· +$3K QoQ· Q1 2026
New
Hedge Fund
$13K· 1.4% of total· 0.0% port· 20K sh· — QoQ· Q4 2025